Minerva

“Diabesity” and other stories . . .

BMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f5124 (Published 21 August 2013) Cite this as: BMJ 2013;347:f5124

“Diabesity” is a new compound word that grates on Minerva, but it gets 140 000 hits on Google, 180 hits on PubMed, and already has several websites, so there is probably no stopping its spread. Whatever people choose to call it, the epidemic of obesity induced diabetes among young people in many developed and developing countries is deeply worrying. An Australian registry study in Diabetes Care (2013, doi:10.2337/dc12-2455) compares outcomes in 354 people diagnosed with type 2 diabetes (T2DM) between ages 15 and 30 years with those in 470 people with type 1 diabetes (T1DM) diagnosed at roughly the same age. During a median follow-up period of over 20 years, the T2DM group had significantly greater mortality, and a higher incidence of neuropathy, albuminuria, and macrovascular outcomes. The researchers conclude: “Young-onset T2DM is the more lethal phenotype of diabetes and associated with a greater mortality, more diabetes complications and unfavorable cardiovascular disease risk factors than T1DM.”

Where do you want to die? Palliative care doctors encourage us to ask this question (if not so bluntly), and in the United Kingdom, they have helped to improve the proportion of …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe